Risk grade updatedRisk gradeEvidence verified
17 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3.Business profile
Biomark Health Oy
Biomark Health Oy's registered office is Tampere. It is a limited company. The company was established on 2023-03-22. It operates in the industry of research and experimental development on natural sciences and engineering. In its latest retained statement for 2025-12-31, revenue was €53,354 and operating profit was €5,096.
Business ID 3349657-5ValidUnclaimed company profile
Trusted core data
Public company details from the trade register.
- Business ID
- 3349657-5
- Sector
- Research and experimental development on natural sciences and engineering
- Municipality
- Tampere
- Company form
- Limited company
- Registration date
- 2023-03-22
- Business ID registration date
- 2023-03-06
- Business status
- Valid
- Profile ownership
- Unclaimed company profile
Contact and location summary
Visiting address: Biokatu 12, 33520, Tampere
About Biomark Health Oy
Financial position and key figures for the company.
Biomark Health Oy's location municipality is Tampere. It is a limited company. The company was established on 2023-03-22. It operates in the industry of research and experimental development on natural sciences and engineering. In its latest retained statement for 2025-12-31, revenue was €53,354 and operating profit was €5,096. The latest retained financial statement for 2025-12-31 shows revenue of €53,354 and profit for the financial year of €4,247. Based on the latest retained statement, revenue growth was -3.1%, operating margin was +9.6%, and equity ratio was +83.0%.
Financial highlights
Key figures from the latest financial period.
Latest financial period
2025-12-31
3
1
PRH/XBRL financial statement
Derived indicators
Revenue growth-3.1%
Operating margin9.6%
Equity ratio83.0%
Balance-sheet contextLatest financial period
Cash and bank€39,210Previous: €35,519
Retained earnings€10,582Previous: €3,847
Equity€37,812Previous: €36,484
Liabilities€7,731Previous: €9,224
Current assets€44,544Previous: €35,708
Current liabilities€7,731Previous: €9,224
Financial ratios
Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.
Equity ratioGood
100/100 · Improving
Current ratioGood
100/100 · Improving
Operating profit marginSatisfactory
74/100 · Declining
Registry status and identifiers
Current registry information and identifiers based on YTJ data.
YTJ statusValid
Trade RegisterRegistered
Business ID3349657-5
VAT IDFI33496575
EU IDFIFPRO.3349657-5
MunicipalityTampere
Current registered entries
2023-03-06Registered in Tax Administration (Prepayment Register)
2023-03-22Registered in Tax Administration (Tax Administration)
2023-03-22Registered in Patent and Registration Office (Trade Register)
2023-04-05VAT-liable for business activity in Tax Administration (VAT Register)
Risk certificate
An open-data based company stability and risk signal.
BUSINESS.fi
BUSINESS.fi Luottoluokitus
Profile-specific risk signal based on open data
Automatic gradeNot a credit decision
A3
GoodBiomark Health Oy
Grade unchangedA3 · new analysis 2026-10-17
74/100
Medium
Usable financial evidenceFinancial data included
Same size nationallyDescriptive comparison – does not change the model score.
3189 peersSolvency71%
Better than 71% of peers
Profitability65%
Better than 65% of peers
Liquidity86%
Better than 86% of peers
RegularBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
3 observed filings58 days after period end
81 days after period end
3 consecutive periods
Supporting factors
- Strong equity ratio
- Strong operating profitability
- Healthy short-term liquidity
Risk factors to note
- Elevated industry distress context
Automatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessmentsA3
2026-10-1774/100 · v0.15
A3 → A3A3
2026-09-19 19:2374/100 · v0.14
B3 → A3 · +25 points- Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2025-12-31).
- Evidence quality: Registry and statistical evidence → Usable financial evidence.
B3
2026-09-1449/100 · v0.14
B3 → B3B3
2026-09-1449/100 · v0.13
Oldest retained automatic assessment in this comparisonA3
2026-10-17
open-risk-grade-v0.15
The grade can use open digital financial statement data together with registry signals.
Risk context
When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.
Industry riskelevated
48/100
Industry context is elevated based on normalized open statistical inputs.
Age and continuityNuori
35/100
The company has about 3 years of registry continuity.
Registry and status signalsRajallinen
49/100
Registry history, filing recency, and active register markings are still limited or mixed.
Events & news
Verified events and sourced external company news in one timeline.
Risk grade updatedRisk gradeEvidence verified
19 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B3 → A3.Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B3.Registry timeline
Trade register notifications shown on a timeline.
8 register eventsLatest event: 2026-02-27
Financial statements availability
Available financial statement periods and PRH source filings.
3 financial statement periodsLatest financial period: 2025-12-31
Profile source and ownership
Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.
This company profile has not been claimed yet
Biomark Health Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.